REGN
Regeneron Pharmaceuticals Inc
788.00$
-1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.63 | 11.55 | 12.78 | 11.28 | 19.12 | 21.20 | 22.75 | 63.11 | 44.18 | 40.40 | 38.41 | 45.85 | |
| 0.46 | 0.65 | 0.90 | 1.26 | 1.29 | 1.84 | 2.05 | 2.55 | 3.01 | 3.70 | 4.20 | 5.01 | |
| 2.71 | 3.98 | 4.81 | 4.38 | 3.72 | 4.05 | 3.75 | 5.36 | 6.39 | 7.78 | 8.54 | 9.15 | |
| 3.48 | 6.03 | 4.97 | 0.94 | -2.17 | 2.74 | -7.78 | -8.86 | 5.96 | – | – | – | |
| 0.18 | 1.99 | 1.96 | -7.99 | -6.07 | -1.75 | -13.06 | -17.08 | -2.14 | -0.83 | -5.37 | 4.90 | |
| 2.93 | 5.88 | 4.40 | 2.35 | 3.34 | 3.75 | 5.34 | 4.92 | 5.20 | 8.15 | 6.57 | 8.27 | |
| -3.71 | -7.88 | -9.00 | -8.67 | -12.74 | -17.69 | -0.61 | -47.99 | -33.34 | -28.01 | -21.44 | -5.79 | |
| 2.60 | 4.75 | 4.30 | 3.09 | – | – | – | – | – | 0.00 | 0.00 | 3.41 | |
| -2.36 | -1.39 | -1.23 | -2.60 | -1.67 | -4.05 | -56.71 | -23.87 | -22.28 | -19.66 | -31.56 | -36.56 | |
| -1.95 | -1.22 | -0.35 | 0.32 | 17.26 | 17.29 | 17.22 | 0.00 | 0.00 | – | – | – | |
| -1.93 | -2.28 | -6.02 | -0.21 | -0.67 | -2.20 | -17.12 | -8.96 | -8.89 | -15.74 | -19.12 | -34.21 | |
| 1.00 | 1.39 | -2.36 | 2.39 | 5.71 | 1.31 | 5.01 | 6.16 | 1.95 | -3.36 | -2.16 | 5.84 | |
| 3.70 | 5.67 | 8.37 | 8.93 | 15.78 | 17.46 | 17.41 | 58.19 | 38.99 | 32.26 | 31.84 | 37.57 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.